This study investigates the efficacy of a novel neuromodulation treatment, light emitting diodes (LED), on cognition, neuropsychiatric status and quality of life in individuals with traumatic brain injury (TBI).
The most common traumatic brain injury (TBI)-associated problems are cognitive deficits and neuropsychiatric problems, such as sleep disturbance and PTSD. This study evaluates a novel neuromodulation intervention, light emitting diodes (LED), for treatment of patients with TBI. LED is a noninvasive, non-thermal, painless treatment, which does not involve any needles or any form of surgery. LED treatment improves cellular activity of the brain tissue that has been damaged by TBI. Half of the study participants will receive active LED treatment, and a control group will receive sham LED. This study takes place in Boston, Massachusetts: at the VA Boston Healthcare System.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
8
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, United States
Cognitive Functioning_Attention/Executive
Stroop Test ("Color-Word" test; Delis, Kaplan \& Kramer, 2001)
Time frame: Eight Weeks
Cognitive Functioning_Learning/Memory
California Verbal Learning Test-II (CVLT-II; Delis, Kramer, Kaplan, \& Ober, 2000)
Time frame: Eight weeks
Neuropsychiatric Status/Mood
Beck Depression inventory (BDI; Beck, 2006)
Time frame: Eight weeks
Neuropsychiatric status/PTSD
PTSD Checklist - Military Version (PCL-M)
Time frame: Eight weeks
Neuropsychiatric status/Sleep
Pittsburgh Sleep Quality Index (PSQI; Buysse et al., 1989)
Time frame: Eight weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.